Skip to content
Home/Companies/Biotech/Aro Biotherapeutics

Aro Biotherapeutics

Biotech·US·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Aro Biotherapeutics?

Aro Biotherapeutics is currently owned by HealthCap through HealthCap VIII (2021 vintage), since 2021.

Hand-verified · updated 2026-08-18

HealthCap
Investor
HealthCap
HealthCap VIII · 2021 · VC

Key facts

HQUnited States
SectorBiotech
StatusActive

More from HealthCap VIII

Other portfolio companies in the same fund.

CurifyLabs
Active
MedTechFinland· 2026
Neobiomics
Active
BiotechSweden· 2026
Gesynta Pharma
Gesynta Pharma
Active
PharmaSweden· 2025
Kivu Bioscience
Active
BiotechUS· 2025
Positrigo
Active
MedTechSwitzerland· 2025
Rampart Biosciences
Active
BiotechUS· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Aro Biotherapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Aro Biotherapeutics?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Aro Biotherapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue